Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2026-03-31 @ 5:46 AM
Study NCT ID:
NCT04557059
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-05
First Post:
2020-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-12
Start Date Type:
ACTUAL
Primary Completion Date:
2029-08-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-08-27
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-17
First Submit QC Date:
None
Study First Post Date:
2020-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED